Skip to content

Noor Hamideh

NPI 1144703554ActiveIndividual· Allergy & Immunology· Chicago, IL

Allergy & Immunology in Chicago, Illinois, licensed in IL, with an NPI issued in September 2018. Part D covered 140 prescriptions written in 2024, 84% of them generic. Genzyme Corporation reported $1,000 in payments in 2025, mostly grants.

Overview

NPI1144703554
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedSep 11, 2018
Last updated in NPPESJun 27, 2025
Certified by providerJun 27, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Allergy & Immunology Primary207K00000X036175180IL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Allergy/Immunology (IL)

Part D prescriptions in 2024

Prescriptions (claims)140 · 295 30-day fills
Patients27
Total drug cost$22,527
Generic share84% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,000 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Genzyme Corporation$1,0001

What the 2025 payments were for

  • Grant$1,000 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other allergists in Chicago

All 57 allergists in Chicago · All allergists in Illinois